Emerging Biosimilars In Therapeutics


In the field of biologics, the new avenue has created towards clinicians because explorations have created for better disease management. In the treatment of ailments like psoriasis, rheumatic arthritis, certain cancer inflammation, bowel diseases etc. showed some good outcomes because of using biologics. Biosimilar insulins which are newly formed are likely to enter the insulin landscape as patents for major branded insulin products ready to expire in the next few years. The emerging biosimilar like filgrastim, peg filgrastimrecombinant blood products, therapeutic products vaccine biosimilar, anti-bodies growth hormones, biosimilar peptide, all these are used to sound knowledge on biosimilars development on drugs.



 

    Related Conference of Emerging Biosimilars In Therapeutics

    June 13-14, 2024

    30th Asia Pacific Biotechnology Congress

    Dubai, UAE
    July 11-12, 2024

    6th International Conference on Biochemistry

    Paris, France
    September 25-26, 2024

    20th World Congress on Structural Biology

    Paris, France
    October 03-04, 2024

    15th International Conference on Biofuels and Bioenergy

    Singapore City, Singapore
    December 12-13, 2024

    15th World Congress on Cell & Tissue Science

    Rome, Italy

    Emerging Biosimilars In Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in